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ABSTRACT 
 
Malaria is one of the most common infectious diseases found in developing and 
tropical regions of the world. It is contracted over 200 million times annually, almost 
800,000 of which are fatal. The primary causative agent of malaria is Plasmodium 
falciparum, a parasite of the phylum Apicomplexa, members of which are characterized by 
an essential non-photosynthetic organelle called the apicoplast. Like the chloroplast and 
mitochondria, the apicoplast contains its own genome, which needs to be properly replicated 
with each cell division for continued survival. To date, the gene PfPREX, a novel 
polyprotein, encodes for the only known helicase, primase, and polymerase involved in 
replication of the genome of the apicoplast. In this investigation we characterized the fidelity 
of the DNA polymerase (apPOL) and examined its ability to extend or remove various base-
paring mismatches. This allowed us to determine the relative likelihood of each 
misincorporation. The purpose of these investigations is to better understand apPOL, which 
is a vital part of the machinery of Plasmodium falciparum as well as a unique polymerase 
itself. While the other two products of PfPREX have been shown to be related to those of T7 
bacteriophage, the most similar polymerase to apPOL is that of DNA polymerase I of 
Aquifex aeolicus, a thermophilic bacteria. It is also part of a small group of polymerases that 
are related to but distinct from prototypical A-family DNA polymerases. For these reasons 
we have chosen to investigate this important DNA polymerase. 
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CHAPTER I 
INTRODUCTION 
 
General Introduction 
Malaria 
 Malaria is one of the most important and widespread diseases of humans. In 2010 
around 216 million cases were reported, including 655,000 deaths.1 The disease is caused by 
transmission of one of five species of Plasmodium protozoan by Anopheles mosquitoes. The 
species of Plasmodium that is prevalent depends on the region, with Plasmodium falciparum 
being the most common, as well as the most dangerous.  
 Transmission rates of malaria depend primarily upon the particular species of 
Anopheles that is present locally; with biting frequency, density, and whether or not 
mosquitoes are present seasonally or all year being important factors.2 Because of this, only 
around 25 of the over 400 species of Anopheles make for good vectors.3  
 There have been many efforts at malaria prevention which have had various degrees 
of effectiveness in different regions. One of the primary methods of prevention used is vector 
control, or control of the Anopheles mosquitoes which transmit malaria. This can be 
accomplished in a variety of ways; one of the most common is by deploying mosquito nets to 
be used while sleeping. These can be treated with insecticides, which has been shown to 
greatly reduce mortality in children in areas where deployed.4 Efficacy of bed nets, especially 
insecticide treated nets, is generally very high, however in some areas the main species of 
Anopheles isn’t active during sleeping hours when the nets are used; this causes them to have 
minimal effects in these areas. Use of insecticides indoors is another important area for 
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vector control, though again efficacy can depend on the local Anopheles species behavior and 
whether resistance has developed.2 
  Currently, artemisinin combination treatment is the preferred method of treatment for 
typical Plasmodium malaria infections.  However, in recent years, resistance to these 
treatments has arisen in western Cambodia and along the Thailand-Myanmar border.5 This is 
the same region that in the past has first shown resistance to previously used antimalarials 
before spreading to other regions, therefore the need for new antimalarial drugs is high.  
Plasmodium falciparum 
 Plasmodium falciparum is the primary causative agent of malaria in sub-Saharan 
Africa and much of Asia, and accounts for around 90% of all cases of malaria worldwide 
each year.1 P. falciparum has a complex, multi-stage life-cycle which is intrinsically tied to 
the symptoms of malaria (Figure 1).2,6 Infections begin when an infected female Anopheles 
mosquito bites a human, transmitting sporozoites into the host body which then travel to the 
liver. In the liver sporozoites reproduce inside liver cells for around one week before 
eventually bursting, releasing merozoites into the bloodstream which proceed to infect red 
blood cells. The characteristic fever peaks of malaria are caused by cycles of asexual 
reproduction in human red blood cells which cause the cells to burst, releasing new 
merozoites into the system. Some merozoites eventually develop into gametocytes which 
then are transmitted into a mosquito vector where sexual reproduction occurs. 
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The Apicoplast 
 Plasmodium falciparum is a member of the phylum Apicomplexa which is primarily 
characterized by the presence of a non-photosynthetic, chloroplast-like organelle called the 
apicoplast. The apicoplast has been shown to be essential for survival of Plasmodium, though 
loss of the apicoplast isn’t immediately fatal, however, it results in a “delayed death” where 
the parasite can survive until the cell divides; after division the progeny are unviable.7,8 
Because of the importance of the apicoplast for survival of the organism, much work has 
been done to elucidate its essential functions as well as attempts at finding potential drug 
Figure 1. The human phase of the falciparum life cycle begins when sporozoites enter the 
blood stream after a bite from a female Anopheles mosquito. Sporozoites make their way 
to the liver where they enter a hepatocyte and begin to multiply. After around one week 
the hepatocytes burst and merozoites enter the blood stream to infect blood cells. In this 
stage merozoites reproduce asexually, with some individuals eventually developing into 
sexual forms (gametocytes). The parasites are stuck in this phase until they are taken up 
by a feeding mosquito where they are able to reproduce sexually, eventually forming a 
new generation of sporozoites which are again able to infect a human host. Figure 
adapted from reference 2.   
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targets.9 One of the reasons apicoplast functions are attractive for drug targets because is 
because of the uniqueness of the apicoplast.  
 The apicoplast is a four-membraned organelle which is thought to have arisen through 
a secondary symbiotic event where a photosynthetic algae was endosymbiosed by a different 
eukaryotic phagotroph.6 Subsequently, the apicoplast has lost its photosynthetic ability (with 
one recently discovered exception, Chromera velia).6 In addition, much of the genetic 
material of the organism that became the apicoplast has been transferred to nucleus, leaving 
behind a 35kb circular genome. Because of this, much of the machinery needed for upkeep of 
the apicoplast must be transported into the apicoplast. Bioinformatics analyses of the 
Plasmodium falciparum genome has shown an estimated 466 proteins that are targeted to the 
apicoplast from the nuclear genome.10  
 
 
Figure 2. Origin of the apicoplast. The apicoplast came about from two endosymbiotic 
events, giving rise to its characteristic four membranes. (Not to scale). Figure adapted 
from reference 6. 
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Pfprex and apPOL 
 One of the genes targeted to the apicoplast is PfPREX (Plasmodium falciparum 
Plastidic DNA Replication/Repair Enzyme Complex), which encodes for a polyprotein that 
contains the DNA primase, helicase, and replicative polymerase involved in replication of the 
apicoplast genome (Figure 3).11 This gene is notable for being the first known example of a 
single gene encoding for each of a DNA primase, helicase, and polymerase.11 Interestingly, 
while the primase and helicase have been shown to be distantly related to T7 bacteriophage 
primases and helicases, the DNA polymerase of PfPREX is most closely related to the DNA 
polymerase I (an A-type polymerase) of Aquifex aeolicus, a thermophilic bacteria.11  
 Interference with these proteins, as well as others involved in replication of the 
apicoplast’s genome, are thought to be the source of the “delayed death” effect observed after 
treatment with certain antibiotics.12 For example, the apicoplast-targeted protein 
Topoisomerase II has been shown to be inhibited by ciprofloxacin, a type of 
fluoroquinolone.13 The DNA polymerase (apPOL) is especially interesting as a drug target 
because it is highly divergent from human polymerases and even other A-family 
polymerases; the highest level of sequence homology with human polymerases is less than 
25%.14 Because of the interest in knowing more about the workings of the replication 
Figure 3. Illustration of PfPREX gene in Plasmodium falciparum.  
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machinery of the apicoplast genome, our lab has started investigating the properties of the 
proteins expressed by PfPREX. 
Thesis Outline 
For my M.S. thesis project I examined the biochemical properties of apPOL, the apicoplast-
targeted DNA-polymerase encoded in the PfPREX gene of Plasmodium falciparum. Chapter 
two contains a study published in the journal Biochemistry, which examines the fidelity, 
mismatch extension, and proofreading abilities of apPOL. Chapter three has a general 
conclusion which will discuss the findings of this research project as well as future directions 
for the project. 
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CHAPTER 2 
FIDELITY, MISMATCH EXTENSION, AND PROOFREADING ACTIVITY OF THE 
PLASMODIUM FALCIPARUM APICOPLAST DNA POLYMERASE 
 
Modified from article published in Biochemistry, 2013, 52 (44), pp 7723–7730. 
 
Bentley M. Wingert, Eric E. Parrott, Scott W. Nelson 
Abstract 
Plasmodia falciparum, a parasitic organism and one of the causative agents of 
malaria, contains an unusual organelle called the apicoplast.  The apicoplast is a non-
photosynthetic plastid responsible for supplying the parasite with isoprenoid units and is 
therefore indispensable.  Like mitochondria and chloroplast, the apicoplast contains its own 
genome and harbors the enzymes responsible for its replication.  In this report, we determine 
the relative probabilities of nucleotide misincorporation by the apicoplast polymerase 
(apPOL), examine the kinetics and sequence dependence of mismatch extension, and 
determine the rates of mismatch removal by the 3’ to 5’ proofreading activity of the DNA 
polymerase.  While the intrinsic polymerase fidelity varies by over 50-fold for the twelve 
possible nucleotide misincorporations, the most dominant selection step for overall 
polymerase fidelity is carried out at the level of mismatch extension, which varies by more 
than 350-fold.  The efficiency of mismatch extension depends on both the nature of the DNA 
mismatch and the templating base. The proofreading activity of the twelve possible 
mismatches varies less than 3-fold.  The data for these three determinants of polymerase-
induced mutations indicate that the overall mutation frequency of apPOL is highly dependent 
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on both the intrinsic fidelity of the polymerase and the identity of the template surrounding 
the potential mismatch.    
Introduction 
Malaria kills nearly 800,000 people each year with the majority of those deaths 
occurring in children under five years of age1.  Over 40% of the world’s population live in 
areas where malaria is a serious health risk and there are approximately 225 million new 
diagnosed cases each year1.  Resistance to commonly used malaria drugs is spreading, such 
that chloroquine and sulfadoxin-pyrimethamine are largely ineffective in parts of Brazil, 
central Africa, India, and south-east Asia2.  It is imperative that new drugs for the treatment 
of malaria be developed, preferably those that target novel aspects of the parasite’s biology 
for which resistance has not already developed3.   
The human parasite Plasmodia falciparum is a member of the phylum Apicomplexa 
and the most common causative agent of malaria4.  Apicomplexa also contains the causative 
agents of several other economically important animal diseases such as Toxoplasmosis 
(human and feline), Babesiosis (cattle and human) and Coccidiosis (poultry)5.  Nearly all 
members of Apicomplexa contain an unusual organelle called the apicoplast.  The apicoplast 
is evolutionarily related to the chloroplast and is thought to have arisen through a symbiotic 
event with red algae4.  The function of the apicoplast has been enigmatic until recently.  The 
apicoplast participates in several metabolic pathways, including the biosynthesis of fatty 
acids, heme, iron-sulfur clusters, and isoprenoids6.  The parasite is completely dependent on 
the apicoplast for the synthesis of isoprenoids and defects in apicoplast metabolism, or its 
failure to replicate and divide lead to death of the organism7.  Due to the essential nature of 
the apicoplast and its uniqueness among eukaryotes, the apicoplast has been identified as a 
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highly promising drug target8.  It has been estimated that approximately 550 proteins reside 
within the apicoplast with a significant number of those being dedicated to translation (8%), 
transcription (1%), and DNA replication (3%)9.  The proteins that carry-out these 
fundamental processes are absolutely required for apicoplast function and are therefore 
promising drug targets.  Indeed, several antibiotics with confirmed anti-malarial activity 
target the following apicoplast enzymes: the 70S ribosome (clindamycin, tetracycline); 
isoleucine tRNA synthetase (mupirocin); and DNA gyrase (ciprofloxacin)10.   
The P. falciparum apicoplast genome is replicated by an A-family DNA polymerase 
(apPOL) that is clearly of prokaryotic origin.  A recent bioinformatic analysis has shown that 
there are four lineages that are related to, but separate from, the prototypical A-family DNA 
polymerases11.  These four lineages are made up of DNA polymerases belonging to 
thermophilic viruses, Aquificaceae/Hydrogenothermaceae, Apicomplexa (which includes 
Plasmodia), and various unrelated bacteria11.  While many A-family DNA polymerases from 
the “typical” lineage have been extensively characterized at the biochemical and structural 
level (e.g., E. coli Pol I, Taq polymerase, T7 phage DNA polymerase, mitochondrial DNA 
polymerase γ), a thorough characterization of polymerases from the other four distinct A-
family lineages is lacking.  In addition to being a member of one of the atypical A-family 
lineages, apPOL is an attractive drug target due to its role in apicoplast genome replication.  
Although humans contain three A-family polymerases (pol θ, pol ν, and pol γ), the homology 
between apPOL and these polymerases is very low (< 24%).   On the other hand, the 
homology between the apPOLs from the two primary causative agents of human malaria is 
quite high (84% identity between P. falciparum and P. vivax), suggesting that drugs targeted 
against the P. falciparum apPOL would be effective in treating malaria caused by P. vivax as 
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well.  The P. falciparum apicoplast DNA polymerase is expressed as part of a polyprotein 
made up of a DNA primase, helicase, and the polymerase12.  Following import into the 
apicoplast a protease(s) of unknown identity separates the three proteins13.    
Replication-induced mutations are governed by a combination of the fidelity of the 
DNA polymerase (i.e., the probability of inserting an incorrect nucleotide opposite the 
templating base), its ability to extend the mismatch, and its counteracting exonuclease 
activity (i.e., proofreading) 14,15.  The relative contribution of each of these processes is often 
overlooked and DNA polymerase fidelity is the focus of most studies16–18.  The fidelity of a 
fragment of P. falciparum apicoplast DNA polymerase has been recently reported 18.  To 
obtain a more complete picture of the mutagenic profile of apPOL, we have extended these 
studies to include mismatch-extension and proof-reading activity.  Based on bioinformatic 
analysis, a different polymerase fragment was constructed to contain an additional 38 amino 
acids at the N-terminus and our steady-state kinetic analysis indicates that it is significantly 
more active than the previous version, with a fidelity more reminiscent of a replicative DNA 
polymerase18.  It was found that the efficiency of mismatch extension is more important to 
the overall mutation frequency than the intrinsic fidelity of the polymerase.  While the 
proofreading activity of each mismatch is relatively similar, the ability of the polymerase to 
extend a particular mismatch varies by over 350-fold.     
Material and Methods 
Materials– Oligodeoxynucleotides used for mutagenesis were purchased from either 
Integrated DNA Technologies or the Iowa State University DNA Facility.  DNA sequencing 
was performed at the Iowa State University DNA Facility.  Nickel-agarose was purchased 
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from Sigma-Aldrich Chemical Company.  Deoxyribonucleotides were purchased from 
Invitrogen or Sigma-Aldrich.   
 
Cloning of the P. falciparum apicoplast DNA polymerase and creation of the exonuclease 
negative mutant (apPOLexo-)– The open reading frame containing the apicoplast DNA 
polymerase encodes for a poly-protein made up a DNA primase, helicase, and polymerase12.  
A linker region between the primase and helicase is proteolytically cleaved and it is assumed 
that the protein is cleaved between the helicase and polymerase as well13.  Based on protein 
sequence alignments of POM1 from the Plasmodia genus, a likely boundary for the 
polymerase protein spanning amino residues 1389 through 2016 was identified.  This protein 
sequence was then converted to DNA sequence using optimal E. coli codons and synthesized 
(Genescript).  The synthesized gene was sub-cloned from the puc18 vector into the pet28b 
expression vector using the NdeI and BamHI restriction sites.  The Quickchange method of 
mutagenesis was employed to produce the exonuclease negative mutant (apPOLexo-).  The 
sequence of the forward primer used for mutagenesis is as follows: 5’-
gatattaaatattgcggcctgaatatccaaaccacgggtctggaagtg-3’ with the codons for the D1470N and 
E1472Q mutations are shown in bold.  The reverse primer was the reverse complement of the 
forward.         
 
Protein Expression, and Purification– The purification protocol for the wild-type (apPOL) 
and exonuclease deficient (apPOLexo-) polymerases were identical.  Either the pet28-apPOL 
or pet28- apPOLexo-  vectors were transformed into BL21(DE3) E. coli cells and a single 
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colony was used to inoculate 100-ml flasks of LB-kanamycin that were shaken for 16 h at 37 
°C.  A 10 ml of starter culture was used to inoculate two 1-liter flasks of LB-kanamycin per 
protein, which were shaken at 225 rpm at 37 °C to an A600 of 0.8.  The flasks were then 
cooled to 18 °C, and expression was induced by the addition of 0.2 mM (final) isopropyl 1-
thio-β-d-galactopyranoside.  After 16 h the cells were collected by centrifugation at 4000 × g 
for 20 minutes, and pellets were frozen at −20 °C. 
Target protein purification relied on a hexahistidine tag provided by the pet28 vector.  
Cell pellets containing expressed apPOL or apPOLexo- (2 liters) were resuspended in 100 ml 
of Loading Buffer (20 mM Tris-HCl, 500 mM NaCl, 5 mM imidazole, 20% glycerol at pH 
8.0 [4°C]) and stored frozen at -20°C.  Following thawing, lysis was accomplished by 
passage thru an EmulsiFlex-C5 (Avestin, Inc.) at ~16 kpsi.  The lysate was clarified by 
centrifugation at ~32,500 x g and the supernatant loaded onto ~ 3 mL of Ni-Agarose resin.  
The column was washed with 100 mL of Loading Buffer, followed by 100 mL of High Salt 
Buffer (5 mM imidazole, 1 M NaCl, 20 mM Tris-HCl, 20% glycerol at pH 8.0 [4°C]) and 
then 30 mL (10 column volumes) of Ni Wash Buffer (20 mM Tris-HCl, 500 mM NaCl, 20 
mM imidazole, 20% glycerol at pH 8.0 [4°C]).  The protein was eluted with Elution Buffer 
(20 mM TRIS-Cl, 200 mM NaCl, 150 mM imidazole, 20% glycerol at pH 8.0 [4°C]).  The 
fractions containing protein were pooled and loaded onto 320 mL HiLoad™ 26/60 
Superdex™ 200 prep grade column equilibrated with 20 mM TRIS-Cl, 400 mM NaCl,  20% 
glycerol at pH 8.0 (4°C).  The column was washed with 400 mL of 20 mM TRIS-Cl, 400 
mM NaCl,  20% glycerol at pH 8.0 (4°C).  The fractions containing protein were pooled and 
the concentration determined spectrophotometrically using an extinction coefficient (ε280 = 
56,750 M-1cm-1) calculated from the deduced protein composition. 
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Steady state Polymerase Extension Kinetics– DNA templates were made by annealing a 20-
nucleotide primer (P1 in Supplemental Table S1) that had been separately 32P-labeled using 
T4-polynucleotide kinase to a 26-nucleotide fragment (T2, T5, T10, & T14). Reactions were 
performed at 25oC in 50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium 
acetate, 1 mM dithiothreitiol, and 0.1 mg/ml bovine serum albumin. Polymerase was diluted 
in a 20 mM Tris-HCl, 200 mM NaCl, and 0.1 mg/ml BSA (standard buffer) prior to addition 
to the reaction. For correct nucleotide incorporations, steady-state assays were performed 
with 2 µM DNA substrate, 8 nM apPOLexo- , and varying amounts of the correct dNTP.  For 
the misincorporation reactions, apPOLexo- concentration was increased to either 80 or 200 
nM, depending on the observed rates in preliminary assays.  Enzyme concentration was 
increased so that approximately ~10-20 % of the substrate was converted to product at the 
longest time point used.  The correct nucleotide following the misincorporation position (to 
allow for run-off synthesis) was held at a concentration of 20 µM.  The reactions were 
initiated at time zero by mixing equal volumes of the DNA polymerase and the DNA 
substrate/nucleotides.  Reactions were quenched after various times with equivalent volumes 
of mixture containing 0.1M EDTA and 80% (v/v) formamide.  Reaction products were 
resolved with 20% denaturing PAGE containing 7.5 M urea in 1X Tris-Borate-EDTA (TBE) 
buffer.  Gels were run for 3 – 3.5 h at a constant power of 60 W, visualized using a Typhoon 
Phosphorimager, and analyzed using the ImageJ software (NIH). The initial rate velocities 
were averaged (each assay was performed 2-5 times) and fitted to the Michaelis-Menton 
equation.  The errors given for each parameter (kcat and Km) are standard errors to the fit.   
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Steady state Mismatch Extension Kinetics– The 48 different substrates that were used to 
investigate the mismatch extension kinetics of apPOLexo- were as follows: P2 with T1-T4 and 
T9-T16; P3 with T5-T16; P4 with T1-T12; and P5 with T1-T8 and T13-T16 (Supplemental 
Table S1).  The reactions were performed in the standard assay buffer at 25oC and contained 
2 µM DNA, 80 nM apPOLexo-, and 2 mM dNTP, and were quenched at times points ranging 
from 1.25 to 60 minutes, depending on the reaction.  Analysis of the gel products was the 
same as above and the rates are averages of three independent reactions.   
 
Steady-state exonuclease Kinetics – The exonuclease experiments were performed using 8 
nM apPOL, 2 µM DNA and were quenched at time points of 1 and 5 minutes. Substrates 
used for these experiments were P2-P5 annealed to each of T2, T6, T10, and T14. Analysis 
of the gel products was the same as for the mismatch extension kinetics and the rates are 
averages of two independent reactions. 
Results and Discussion 
P. falciparum apPOLexo- Misincorporation Kinetics– The mutagenesis frequency of a 
DNA polymerase depends on several factors.  The first is the intrinsic fidelity of the 
polymerase active site (i.e., the probability of incorrect nucleotide incorporation), which is a 
commonly examined property of DNA polymerases and several different methods have been 
used to determine it, including pre-steady state kinetics, steady-state kinetics, and direct 
competition assays19.  Apparently, all three methods yield similar results, although there are 
theoretical concerns with using single-nucleotide incorporation steady-state kinetics when the 
dissociation rate of the polymerase from the DNA product is very rate-limiting20.  Slow 
16 
 
product dissociation may occur when a highly processive polymerase is stalled at a correctly 
matched n+1 DNA product and cannot continue polymerizing due to omission of the next 
correct nucleotide21.  To decrease the effect this potential concern, the DNA templates were 
designed to contain a five nucleotide homopolymeric extension and a low concentration (20 
µM) of the correct nucleotide for incorporation across the repeat is included in the reactions.  
Control reactions indicate that at this low concentration the nucleotide does not incorporate 
across from the position of interest, yet the nucleotide tail is very rapidly filled in.  A 
substrate of this type allows a processive polymerase to quickly “run-off” the DNA substrate 
via five rounds of very rapid nucleotide incorporations.   
 The steady-state kinetic parameters of the exonuclease deficient apPOLexo- for the 
four correct nucleotide incorporations and nine out of the twelve possible mismatches are 
given in Table I.  The values determined here for apPOLexo- do not correspond well to a 
previous investigation using a shorter version of the P. falciparum apicoplast DNA 
polymerase18.  The most striking difference between the two reports is that our kcat values 
are significantly greater (approximately 750-fold) than those of Kennedy et al.  (average 
kcat(correct) of 0.3 sec
-1 for our construct versus 0.00044 sec-1 for theirs).  The reason for this 
very large discrepancy is not clear.  The polymerase construct used in our studies contains an 
extra 38 residues at the N-terminus, which are partially conserved only within the genus 
Plasmodia and are not found in other DNA polymerases (Supplemental Fig. S1).  The 
absence of these residues may be responsible for the much reduced activity.  It is also 
possible that the reduced kcat values reported by Kennedy et al. are due to the unusual 
conditions used for their steady state polymerase assays.  The DNA substrate concentration 
used was low (10 nM) and possibly not at a saturating concentration.  Additionally, the 
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polymerase concentration that was used (20 nM) exceeded that of the substrate concentration 
by 2-fold, indicating that the reported values should not be considered true steady-state 
kinetic parameters22.  These types of conditions (low DNA concentration/protein excess) also 
have the potential to obscure potential problems due to dNTP contamination.  For example, 
kinetic time courses revealed that our original source of dTTP was contaminated with dATP 
at a level of approximately 0.02%.  Contamination can be identified by non-linear initial 
velocity kinetic time courses that display a faster phase with an amplitude greater than 
enzyme concentration.  To observe this phase, the DNA concentration must be greater than 
the concentration of the contaminating nucleotide.  If not, then the resulting kinetic data may 
produce kcat values similar to correct incorporation and elevated Km values that are linked to 
the percent contamination and the kcat/Km for the intended dNTP.  In our unpublished 
assays using polymerase concentrations in excess of DNA substrate (i.e., pre-steady state 
kinetic assays), the substrate is completely converted to product in less than 2 seconds when 
the correct dNTP is used (an average kpol of ~20 sec-1) (Parrott, Wingert, and Nelson, 
unpublished results).  The relatively slow rates previously reported18 (5 minutes for ~10% 
substrate conversion under polymerase excess conditions) is consistent with either a 
polymerase defect or the polymerase has a Kd-DNA that is significantly above 10 nM.   
 In addition to significantly greater kcat values for correct nucleotide incorporation, a 
much wider variation in kcat values between correct and incorrect incorporations was 
observed (Table I).  In the previous study, the kcat values ranged from a 13.7-fold decrease to 
a 1.5-fold increase for incorrect versus correct incorporation18.  The decrease in kcat values 
reported here for incorrect incorporation range from 412- to 54-fold.  This magnitude of 
decrease is within a similar range as most other well-characterized high-fidelity DNA 
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polymerases19,23.  Again, the differences between the previously published data and those 
reported here may be the result of using different polymerase constructs or different methods 
of kinetic analysis.   
There is also a lack of correspondence between the Km-dNTP data reported here and 
the values reported by Kennedy et al., although not as great as with the kcat values.18  As 
expected, we find that the purine nucleotides to have a smaller Km than the pyrimidine 
nucleotides (1.7 and 0.7 µM for dATP and dGTP, respectively, versus 5.1 and 7.3 µM for 
dTTP and dCTP, respectively).  There are no clear trends in the misincorporation data, other 
than pyrimidine-pyrimidine misincorporations tend to be strongly disfavored.   
The fidelity of a polymerase can be determined by the ratio of 
(kcat/Km)incorrect/(kcat/Km)correct
24,25.  Based on this formula, the fidelity of apPOLexo- ranges 
from 3.86 x 10-4 for the most likely misincorporation (dTTP:dGMP) to less than 1.07 x 10-5 
for the least likely misincorporations (dCTP:dCMP,  dCTP:dTMP, and dTTP:dTMP), where 
the first position represents the incoming nucleotide and the second is the template (i.e, 
primer:template) (Table 1).  The data indicates that our limit of detection, while still 
maintaining true steady-state conditions (DNA>> apPOLexo-), is around a kcat value of 
0.0006 sec-1.  The fidelity values we have determined are approximately 5-fold smaller than 
previous measurements, which is likely a reflection of the larger differences in kcat between 
correct and incorrect incorporations that is observed here.  However, the correspondence 
between our relative ranking of misincorporations based on fidelity measurements and those 
previously is, for the most part, quite good (Table I and reference 18).  Two of the three most 
likely misincorporations are identical between this and the earlier report (dTTP:dGMP  and 
dGTP:dTMP), and two of the three least likely misincorporations are the same as well 
19 
 
(dCTP:dCMP and dTTP:dTMP).  The only significant differences between the this report 
and the previous one in terms of the fidelity calculation are the dATP:dAMP (2nd and 7th 
most likely, respectively) and dCTP:dTMP (10th and 5th most likely, respectively) 
misincorporations.  The source of these discrepancies is unclear, but it appears that our 
polymerase construct behaves more similar to Klenow polymerase, where dATP:dAMP is 
also the 2nd most likely mutation and dCTP:dTMP is the 11th most likely using steady-state 
kinetic methods.   
DNA Mismatch Removal and Extension– A qualitative examination of the misincorporation 
gels indicated that some mismatches were easily extended to the end of the DNA substrate, 
whereas other mismatches appeared to extend only to the n+1 and n+2 positions.  This 
observation prompted an investigation of the second factor that governs mutation frequency, 
which is the ratio between the rate of mismatch removal (i.e., proofreading) and the ability of 
the polymerase to extend the mismatch15.  The mismatch removal rate is relatively constant 
for all 12 possible DNA mismatches (less than 3-fold variation, Table II) but is 2- to 14-fold 
faster than removal of the four correctly-matched base pairs.  In contrast to mismatch 
removal, the rate of mismatch extension varies much more widely (greater than 350-fold), 
depending on both the nature of the mismatch and the templating base that follows the 
mismatch (Fig. 1, 2, and 3).  Because it was initially observed that the downstream 
templating base strongly affected mismatch extension frequency (Fig. 2), the 12 base pair 
mismatches with all four possible templating bases were examined (i.e., 48 total DNA 
substrates).  Due to the large number of DNA substrates, a determination of Km and kcat for 
each substrate was beyond the scope of this investigation and therefore only the apparent-
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kcat for each mismatch extension reaction was determined using nucleotide concentration 
that was assumed to be saturating or near-saturating (2.0 mM dNTP).       
There are several general trends that are observed in the mismatch extension data 
(Figures 1 and 3).  The most efficiently extended mismatches tend to be purine-pyrimidine or 
pyrimidine-purine (G:T, C:A, A:C, and C:T) and the least efficiently extended mismatches 
are purine-purine and pyrimidine-pyrimidine (A:A, T:T, A:G, and T:C).  Although useful, 
the average apparent-kcat values for mismatch extension given in Fig. 1 obscures the 
significant dependency of mismatch extension efficiency on the templating base that follows 
the mismatch.  For example, the C:A mismatch is extended with a relatively high rate when T 
or C is the templating base (C:AT and C:AC), but is much less efficient when A is the 
templating base (C:AA).  In the case of the A:C mismatch, only the DNA substrate with a 
templating T supports a high rate of mismatch extension (A:CT).  This pattern could possibly 
be the result of primer slippage (i.e., the mismatched template nucleotide looping out and 
allowing the primer to anneal to the downstream base); however, a close analysis of the gel 
indicated that the product of this reaction was of the expected length, indicating that a primer 
slippage did not occur.    
An analysis of the data shown in Fig. 3 allows some general conclusions to be drawn 
from the templating nucleotide data.  Mismatches are most efficiently extended when the 
templating base is a pyrimidine rather than a purine, with average apparent kcat values of 
0.02 and 0.005 sec-1, respectively.  The strong sequence dependence that is observed in the 
mismatch extension reactions suggests that the incoming nucleotide plays a significant role in 
compensating for alterations in the structure of the polymerase active site due to upstream 
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mismatched DNA.  As purines provide more binding energy than pyrimidines, it is not 
unexpected that these nucleotides are able to provide a greater compensatory effect. 
 Based on our misincorporation, exonuclease, and mismatch extension data, we have 
ranked possible mutations from the most to least likely to occur (Fig. 4).  These values were 
obtained by multiplying the fidelity by the ratio of mismatch extension to mismatch removal 
rate [ranking = fidelity*(extension/removal)].  While these values do not represent a kinetic 
constant and have no true physical meaning, they are useful for comparisons.  The intent of 
this calculation is to take into account all three selection steps that govern mutagenesis 
frequency.  The higher the value, the more likely it is that a particular mutation will occur.  
Based on these values, the four most likely mutations are the transition mutations GA 
when a T is the downstream base and TC when T, C, or G is the downstream base.  There 
are only a few transversions ranking in the upper third of the most likely mutations (Fig. 4A).  
Those are AC when C is the downstream base, AT when G or T is the downstream base, 
and G T when A is the downstream base.   
There is a lack of correspondence between the relative rankings for mismatch 
extension and misincorporation probability (Fig. 1 and Table I).  For example, A:A and G:A 
are ranked 2nd and 5th for misincorporation probability but 10th and 9th for mismatch 
extension, respectively (using the averaged data from Fig. 1).  On the other hand, the C:A 
and A:C mismatches are 7th and 8th for misincorporation probability but 2rd and 3th for 
mismatch extension, respectively.  The opposing rankings for these mutations lessen the 
effects of either low fidelity or high mismatch extension rate, reducing the probability that 
they will occur.  The most notable exception to this pattern is G:T, which is ranked near the 
top in both misincorporation probability and mismatch extension.     
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Of course, the rank-order of the mutations shown in Fig. 4 may not entirely reflect the 
order of polymerase-induced mutation probability in the apicoplast of P. falciparum.  Very 
little is known regarding mismatch repair within the apicoplast.  Inspection of the P. 
falciparum genome revealed several genes encoding putative DNA repair proteins that 
appear to contain apicoplast targeting signals26.  One of these proteins contains a MutS 
domain and the typical ABC motifs of MutS homologs, therefore some form of mismatch 
repair may occur within the apicoplast.  Human MutS appears to show no strong preference 
for any particular mismatch (less than 2-fold differences)27, whereas prokaryotic MutS 
displays large differences in efficiencies28.  Notably, the mismatch least efficiently repaired 
(pyrimidine-pyrimidine) is also the least likely to occur. 
 The fidelity and mutagenic potential are of considerable importance to the biology of 
the Plasmodia because its apicoplast apparently contains only a single DNA polymerase.   
High fidelity is necessary for preserving genetic information and avoiding harmful mutations 
that may lead to organismal dysfunction, whereas mutagenesis is necessary for generating 
genetic diversity and the long-term evolution of a species.  The fidelity measurements 
reported here clearly place apPOL in the group of high-fidelity DNA polymerases with error 
rates ranging from 10-4 to less than 10-6.   Unlike the mitochondria and apicoplast, which 
contain only a single DNA polymerase, most organisms harbor several low-fidelity 
polymerases that are responsible for replicating past DNA lesions (i.e., translesion synthesis 
polymerases).  The high fidelity of apPOL suggests that DNA lesions are not easily bypassed 
and it is likely that the apPOL stalls at most or all types of DNA lesions.  This suggests the 
existence of DNA repair pathways like those found in the mitochondria (e.g, base excision 
repair)29.  As mentioned above, there are several proteins containing predicted apicoplast 
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targeting signal sequences that are annotated as DNA repair proteins and it appears a base 
excision repair system may be present26.  The replication and repair of the P. falciparum 
apicoplast genome is poorly characterized and with the ever-increasing drug resistance of P. 
falciparium, combined with the potential of the apicoplast as a drug target, determining the 
fundamental mechanisms of the apicoplast genome replication and repair is an important step 
toward finding new malaria treatments that target novel aspects of the parasites biology.   
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Figure Legends 
Figure 1.  The average apparent-kcat for mismatch extension.  The first letter of the DNA 
substrate represents the base at the 3’ end of the primer strand and the letter following the 
colon represents the template base that is mismatched with the primer (primer:template).  
Each value is an average of the apparent-kcat values for all four templating nucleotides (e.g., 
G:TT, G:TA, G:TC, and G:TG).   
 
Figure 2.  Polyacryamide gel analysis of the G:T mismatch extension reaction.  The 
primer and the end of the template are indicated by the arrows on the right and left sides of 
the gel, respectively.  In reactions performed with dATP and dGTP, the addition of a single 
3’ overhanging nucleotide is often observed.  The time points for each reaction are:  0, 1.25, 
2.5, 5, 10.75, 15, 20, & 30 minutes. 
 
Figure 3.  The individual extension rates for the twelve possible mismatches with each 
templating base.  The first letter of the DNA substrate represents the base at the 3’ end of 
the primer strand, the letter immediately after the colon represents the base that is incorrectly 
paired with the primer, and the last letter represents the templating base for the correct 
incoming nucleotide.  The values are considered to be apparent-kcat values as they were 
performed at saturating or near-saturating dNTP concentrations.  The rates were derived 
through analysis of polyacrylamide gels such as the one shown in Figure 2.  Reactions that 
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showed no detectable product over the entire time-course of the reaction were considered to 
be zero.      
 
Figure 4.  Rank order of polymerase-induced mutation probability based on intrinsic 
fidelity, mismatch extension activity, and exonuclease rate.  As described in the text, the 
calculated values are for comparison purposes only and do not represent a true kinetic 
constant.  A) The 17 DNA substrates with the highest calculated values.  B) The 31 DNA 
substrates with the lowest calculated values.  Note the 100-fold difference in the y-axis scale 
between A and B.       
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Tables and Figures 
Table 1 
Steady-state Kinetic Parameters of P. falciparum Apicoplast DNA polymerasea for Correct and 
Incorrect Nucleotide Incorporations 
Nucleotide Template kcat Errora Km Errora kcat/Km Fidelityb 
  sec-1  M  sec-1M-1  
dTTP dAMP 0.33 0.01 5.1 0.7 0.065 1 
dATP dAMP 0.0026 0.0001 148 31 1.76E-05 2.71E-04 
dGTP dAMP 0.0012 0.0005 262 66 4.58E-06 7.08E-05 
dCTP dAMP 0.0013 0.0001 345 134 3.77E-06 5.82E-05 
         
dATP dTMP 0.34 0.02 1.7 0.4 0.2 1 
dGTP dTMP 0.0034 0.0001 73 11 4.66E-05 2.33E-04 
dCTP dTMP N.D.a N.D. N.D. N.D. N.D. N.D. 
dTTP dTMP N.D. N.D. N.D. N.D. N.D. N.D. 
         
dCTP dGMP 0.24 0.009 7.3 1.7 0.033 1 
dTTP dGMP 0.0018 0.0005 142 16 1.27E-05 3.86E-04 
dGTP dGMP 0.0006 0.00005 562 127 1.07E-06 3.25E-05 
dATP dGMP 0.0033 0.0002 903 136 3.65E-06 1.11E-04 
         
dGTP dCMP 0.33 0.01 0.7 0.2 0.47 1 
dATP dCMP 0.0061 0.0002 241 34 2.53E-05 5.37E-05 
dTTP dCMP 0.0008 0.00007 159 42 5.03E-06 1.07E-05 
dCTP dCMP N.D. N.D. N.D. N.D. N.D. N.D. 
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Table 2 
Steady-state exonuclease rate of P. falciparum Apicoplast DNA polymerasea 
aWild-type polymerase was used.   
bStandard deviation of at least three independent replicates.   
Substrate Apparent kcat Errora 
 sec-1 sec-1 
A:T 0.07 0.01 
A:C 0.36 0.11 
A:G 0.15 0.03 
A:A 0.14 0.02 
   
T:A 0.06 0.03 
T:C 0.37 0.07 
T:T 0.29 0.03 
T:G 0.30 0.05 
   
G:C 0.06 0.03 
G:T 0.32 0.03 
G:G 0.37 0.06 
G:A 0.27 0.05 
   
C:G 0.03 0.01 
C:T 0.28 0.10 
C:C 0.41 0.029 
C:A 0.26 0.08 
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CHAPTER 3 
DISCUSSION AND CONCLUSIONS 
 
Summary 
 Over the course of our investigation of apPOL it has been our goal to describe its 
fidelity and kinetics under various conditions. We first examined the fidelity of apPOL and 
found that its fidelity is comparable to those of high-fidelity A family polymerases.1 We also 
showed that the likelihood of individual misincorporations can vary greatly depending on the 
template and incoming nucleotides and that the largest factor in this is the ability of apPOL to 
extend past the mismatch as opposed to its ability to incorporate the nucleotide or a 
difference in exonuclease activity for each mismatch. We found that fidelity values for each 
mismatch pair varies by around 50-fold but extension kinetic values can vary up to 350-fold 
for values we were able to observe. Once values for fidelity, apparent kcat of extension of 
mismatch, and apparent kcat of the 3’ to 5’ exonuclease removing the mismatch were 
obtained, we generated a constant for each mismatch that would represent its relative 
likelihood of happening for each downstream base. This value was generated using the 
following formula. 
𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑 = 𝑓𝑖𝑑𝑒𝑙𝑖𝑡𝑦 ∗ (
𝑒𝑥𝑡𝑒𝑛𝑠𝑖𝑜𝑛
𝑟𝑒𝑚𝑜𝑣𝑎𝑙
) 
This formula gave us a unit less value that doesn’t represent any actual kinetic 
property but is useful for being able to compare relative likelihoods of each mutation. We 
found that the most likely misincorporations to occur were T being inserted across from G 
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with T as the downstream base and G being inserted across from T with either T, C, or G as 
the downstream base.  
Future Directions 
 I am currently characterizing the ability of apPOL to replicate across a non-coding 
abasic lesion. I’ve found that while the kpol (pre-steady state rate constant) of apPOL 
inserting dATP across from the abasic site was slightly higher than that of inserting dGTP, 
the KD for  dGTP is 2-fold lower than KD for dATP, making the likelihood of insertion of 
dGTP as measured by efficiency (kpol/KD) nearly 2-fold greater than dATP. This is 
significantly different than all other characterized polymerases, which strongly prefer dATP 
over all other nucleotides (the so-called “A-rule”). However, data from preliminary extension 
assays show that the extension of A across from the abasic site is much efficient than G, 
indicating that in the case of apPOL the “A-rule” is enforced at the extension step rather than 
insertion. Next, we examined the 3’ to 5’ exonuclease activity of apPOL and found that its 
apparent kcat value was around ~10-fold higher than the kpol of either dATP or dGTP 
insertion. It was also comparable to the apparent kcat of the exonuclease removing a 
mismatched base. The next step of our investigation of apPOL is to analyze the polymerase’s 
ability to extend past improperly inserted bases across from an abasic site. To do this we plan 
on using a recently described high-throughput method to look at the fidelity of apPOL around 
the abasic site.2 The method involves running the extension reaction as we have before but 
with new DNA templates. The four templates differ at the downstream base adjacent to the 
abasic site as well as around 10 bases upstream, the upstream differences are barcodes there 
to be able to identify each template after sequencing. After running the assay, the products 
are gel purified to isolate the primer strand which is then amplified with a PCR reaction to 
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attach sequences used to attach the ssDNA strands to the slide for sequencing. This method 
will allow us to see how the fidelity of the polymerase is altered across from and downstream 
of the abasic site in different sequence contexts. After finishing the analysis of extension past 
a base incorporated across from an abasic site we will be able to use the same high-
throughput method to investigate apPOL’s activity around other types of DNA damage (e.g. 
pyrimidine dimers, 8-oxoguanine) by changing only the DNA template.  It will also be 
interesting to determine the effects of other proteins found as part of the putative apicoplast 
replisome, such as the helicase, primase, and the single-strand binding protein.  
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